Literature DB >> 30138619

NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis.

Seong-Kyu Kim1, Yoon Jeong Cho2, Jung-Yoon Choe3.   

Abstract

OBJECTIVE: There is some evidence that an enhanced Th17 response is attributable to interleukin-1β (IL-1β) matured by activation of the NLRP3 inflammasome. In this study, we assessed the expression of NLRP3 inflammasome components and their associated proinflammatory cytokines in patients with ankylosing spondylitis (AS).
METHODS: A total of 23 male patients with AS and 29 male controls were recruited and peripheral blood mononuclear cells (PBMCs) were collected. Transcript and protein expression of NLRP3, caspase-1, ASC, IL-1β, IL-17A, and IL-23 were evaluated by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot assay, respectively. Data were analyzed using Spearman's correlation coefficient, Mann-Whitney U test, and receiver operating characteristic curves.
RESULTS: Higher mRNA expression of NLRP3, ASC, IL-1β, IL-17A, and IL-23 was noted in the PBMCs of AS patients than those of controls (p = 0.013, p = 0.001, p = 0.002, p = 0.011, and p = 0.037, respectively). Similarly, protein expression of NLRP3, caspase-1, ASC, IL-1β, IL-17A, and IL-23 was higher in the AS group than the control group. There were significant correlations among NLRP3, caspase-1, ASC, IL-1β, IL-17A, and IL-23 expression in patients with AS, except for a weak association between NLRP3 and IL-17A. Treatment of cultured PBMCs with 10 ng of lipopolysaccharide induced NLRP3, caspase-1, ASC, IL-1β, IL-17A, and IL-23 expression, which was marked suppressed by treatment with ascorbic acid.
CONCLUSION: This study suggests that the NLRP3 inflammasome may be involved in the pathogenesis of AS and therefore a potential therapeutic target in AS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Inflammasome; Interleukin-17; Interleukin-1β; NLRP3

Mesh:

Substances:

Year:  2018        PMID: 30138619     DOI: 10.1016/j.cca.2018.08.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Clinical Significance of Peripheral Blood Th1 and Th17 Cell Content and Serum IL-35 and IL-17 Expression in Patients with Ankylosing Spondylitis.

Authors:  Haitao Tan; Shan Huang; Tingrui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

2.  Clinical Significance of Elevated Serum Caspase-1 Levels in Patients With Ankylosing Spondylitis.

Authors:  Sang-Hyon Kim; Ji-Hyun Lee; Hye-Jin Jeong; Ji-Min Kim; Won-Ki Baek; Tae-Hwan Kim; Jae-Bum Jun; Chang-Nam Son
Journal:  Ann Lab Med       Date:  2022-03-01       Impact factor: 3.464

3.  An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enhancing Binding to NEK7.

Authors:  Emily A Caseley; Samuel Lara-Reyna; James A Poulter; Joanne Topping; Clive Carter; Fatima Nadat; Gavin P Spickett; Sinisa Savic; Michael F McDermott
Journal:  J Clin Immunol       Date:  2021-10-21       Impact factor: 8.317

4.  NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis.

Authors:  Ping Xia; Yu-Quan Shao; Cong-Cong Yu; Yu Xie; Zhi-Jie Zhou
Journal:  BMC Immunol       Date:  2022-08-14       Impact factor: 3.594

Review 5.  Regulatory Role of Apoptotic and Inflammasome Related Proteins and Their Possible Functional Aspect in Thiram Associated Tibial Dyschondroplasia of Poultry.

Authors:  Muhammad Fakhar-E-Alam Kulyar; Wangyuan Yao; Quan Mo; Yanmei Ding; Yan Zhang; Jindong Gao; Kewei Li; Huachun Pan; Shah Nawaz; Muhammad Shahzad; Khalid Mehmood; Mudassar Iqbal; Muhammad Akhtar; Zeeshan Ahmad Bhutta; Muhammad Waqas; Jiakui Li; Desheng Qi
Journal:  Animals (Basel)       Date:  2022-08-10       Impact factor: 3.231

Review 6.  Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases.

Authors:  Zoltán Szekanecz; Iain B McInnes; Georg Schett; Szilvia Szamosi; Szilvia Benkő; Gabriella Szűcs
Journal:  Nat Rev Rheumatol       Date:  2021-08-02       Impact factor: 20.543

Review 7.  Omnipresence of inflammasome activities in inflammatory bone diseases.

Authors:  Yael Alippe; Gabriel Mbalaviele
Journal:  Semin Immunopathol       Date:  2019-09-13       Impact factor: 9.623

Review 8.  The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification.

Authors:  Chenyang Yu; Caihua Zhang; Zhihui Kuang; Qiang Zheng
Journal:  Inflammation       Date:  2020-11-20       Impact factor: 4.092

9.  Micheliolide alleviates ankylosing spondylitis (AS) by suppressing the activation of the NLRP3 inflammasome and maintaining the balance of Th1/Th2 via regulating the NF-κB signaling pathway.

Authors:  Zhong-Gu Tian; Miaomiao Yao; Jie Chen
Journal:  Ann Transl Med       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.